| 2025-11-19 | 8-K | 10.1 | Waiver and Redemption Agreement, dated as of November 13, 2025, by and among Fennec Pharmaceuticals Inc., Petrichor Opportunities Fund I LP, and Petrichor Opportunities Fund I Intermediate LP |
|---|
| 2025-11-18 | 8-K | 10.1 | Form of Subscription Agreement |
|---|
| 2025-03-26 | 10-K | 10.6 | Form of Restricted Stock Award Agreement under 2020 Equity Incentive Plan* |
|---|
| 2025-03-26 | 10-K | 10.5 | Form of Stock Option Award Agreement under 2020 Equity Incentive Plan* |
|---|
| 2024-12-20 | 8-K | 10.1 | Waiver and Redemption Agreement, dated December 18, 2024, between Fennec Pharmaceuticals Inc. and Petrichor Opportunities Fund I LP |
|---|
| 2024-10-30 | 8-K | 10.3 | Executive Employment Agreement between the Company and Christiana Cioffi, effective as of October 28, 2024 |
|---|
| 2024-10-30 | 8-K | 10.2 | Executive Employment Agreement between the Company and Terry Evans, effective as of October 28, 2024 |
|---|
| 2024-10-30 | 8-K | 10.1 | Executive Employment Agreement between the Company and Pierre Sayad, effective as of October 28, 2024 |
|---|
| 2024-08-07 | 8-K | 10.2 | Executive Employment Agreement between the Company and Jeffrey S. Hackman, effective as of August 5, 2024 |
|---|
| 2024-08-07 | 8-K | 10.1 | Confidential Separation Agreement between the Company and Rostislav Raykov, effective as of August 5, 2024 |
|---|
| 2024-07-02 | 8-K | 10.1 | Separation Agreement Adrian Haigh |
|---|
| 2024-03-29 | 10-K | 10.16 | Fennec Pharmaceuticals, Inc. Insider Trading Policy, dated July 11, 2009. |
|---|
| 2024-03-21 | 8-K | 10.1 | License and Supply Agreement, dated March 15, 2024, between Fennec Pharmaceuticals, Inc. and Norgine Pharma UK Limited. |
|---|
| 2023-12-06 | 8-K | 10.1 | First Amendment to the Securities Purchase Agreement |
|---|
| 2023-08-07 | 8-K/A | 10.1 | Employment Agreement Adrian Haigh |
|---|
| 2023-08-04 | 8-K | 10.1 | Employment Agreement Adrian Haigh |
|---|
| 2022-08-01 | 8-K | 10.1 | Securities Purchase Agreement dated as of August 1, 2022 by and between Fennec Pharmaceuticals Inc. and Petrichor Opportunities Fund 1 LP |
|---|
| 2022-01-31 | 8-K | 10.1 | Third Amendment to the Loan and Security Agreement dated as of January 27, 2022 by and among Fennec Pharmaceuticals, Inc. and Western Alliance Bank. |
|---|
| 2021-06-24 | 8-K | 10.1 | Second Amendment to the Loan and Security Agreement dated as of June 24, 2021 by and among Fennec Pharmaceuticals, Inc. and Western Alliance Bank. |
|---|
| 2020-06-26 | 8-K | 10.1 | Loan and Security Agreement dated as of June 25, 2020 by and among Fennec Pharmaceuticals, Inc. and Western Alliance Bank. |
|---|
| 2019-09-09 | 8-K | 10.1 | Employment Agreement Shubh Goel |
|---|
| 2019-06-20 | 8-K | 10.1 | Fennec Pharmaceuticals Inc. Amended and Restated Stock Option Plan (as amended on June 18, 2019). |
|---|
| 2019-02-04 | 8-K | 10.1 | Loan and Security Agreement dated as of February 1, 2019 by and among Fennec Pharmaceuticals, Inc. and Western Alliance Bank. |
|---|
| 2017-09-29 | 8-K | 10.1 | Amended and Restated Stock Option Plan, as amended on September 29, 2017 |
|---|
| 2016-05-12 | 10-Q | 10.42 | Purchase Agreement, dated May 9, 2016, between Fennec Pharmaceuticals Inc. and Elion Oncology, LLC. |
|---|
| 2016-05-12 | 10-Q | 10.41 | Subscription Agreement, dated April 8, 2016, between Fennec Pharmaceuticals Inc. and Sigma Tau Finanzaria |
|---|
| 2015-11-12 | 10-Q | 10.40 | Employment Agreement - Robert Andrade |
|---|
| 2015-03-31 | 10-K | 10.20 | Form of Subscription Agreement from December 3, 2014 private placement |
|---|
| 2014-04-02 | 10-K/A | 10.19 | SUBSCRIPTION AGREEMENT |
|---|
| 2013-06-20 | 8-K | 10.23 | Separation and Mutual Release Agreement by and between Adherex Technologies, Inc. and Dr. Thomas Spector |
|---|
| 2012-11-14 | 10-Q | 10.1 | Amended Master Service Agreement with OCT Group LLC, dated October 29, 2012 (filed herewith). |
|---|
| 2012-08-13 | 10-Q | 10.2 | Notice of Termination of Master Service Agreement between Adhere Technologies, Inc. and Database Integrations, Inc. dated August 2, 2012 (filed August 10, 2012 and incorporated herein by reference). |
|---|
| 2012-08-13 | 10-Q | 10.1 | Amended Master Service Agreement with OCT Group LLC, dated June 4, 2012 (included as Exhibit 10.1 to Form 10-Q of Adherex, filed August 10, 2012, and incorporated herein by reference). |
|---|
| 2011-11-14 | 10-Q | 10.1 | Amended Master Service Agreement with OCT Group LLC, dated August 16, 2011 (included as Exhibit 10.1 to Form 10-Q of Adherex, filed November 13, 2011, and incorporated herein by reference). |
|---|
| 2011-05-13 | 10-Q | 10.1 | Amended Master Service Agreement with OCT Group LLC dated April 2, 2011 (filed herewith). |
|---|
| 2010-11-15 | 10-Q | 10.1 | Master Service Agreement with OCT Group LLC dated August 18, 2010 (filed herewith). |
|---|
| 2010-05-14 | 10-Q | 10.31 | Independent Board Member Agreement – Breen, Bussandri, Porter |
|---|
| 2010-05-14 | 10-Q | 10.30 | Employment Agreement – Dr. Thomas Spector |
|---|
| 2010-05-14 | 10-Q | 10.29 | Employment Agreement – Robert Andrade |
|---|
| 2010-05-14 | 10-Q | 10.28 | Employment Agreement – Rostislav Raykov |
|---|
| 2010-05-14 | 10-Q | 10.27 | Eastowne Lease Agreement |
|---|
| 2009-11-16 | 10-Q | 10.24 | LEASE TERMINATION AGREEMENT AND RELEASE |
|---|
| 2009-11-16 | 10-Q | 10.23 | AMENDED AND RESTATED EMPLOYMENT AGREEMENT |
|---|
| 2009-07-13 | 8-K | 10.23 | SEPARATION AND MUTUAL RELEASE AGREEMENT |
|---|